MCS Dean's Council Members

• Elizabeth W. Andreev, MCS05: Executive Director - UBS Financial Services
• Dr. Konstantin Andreev, MCS02 MCS05: Portfolio Manager, Global Macro - Invesco
• Clarence W. Brown, ENG91: Dermatologist and Director, Mohs Micrographic Surgery, Advanced Skin and Mohs Surgery Center
• Vivian Hui-Wen Cheng, MCS01: Director, R&D Patient Engagement - Takeda
• Dr. Lorraine “Lorrie” K. Doyle, MCS73: Retired
• Dr. Njema J. Frazier, MCS92: Director, Office of Experimental Sciences National Nuclear Security Administration (NNSA) - U.S. Department of Energy
• Brian Frezza, MCS05: Co-Founder & Co-Chief Executive Officer - Emerald Therapeutics & Emerald Cloud Laboratory
• Larry E. Jennings, Jr., MCS84 GSIA87: Senior Managing Director and Co-Founder - ValStone Partners
• John P. Judge, MCS86: Chief Client Strategist - Teneo Holdings
• Tim Kenny, MCS85: Managing Director - Barings LLC
• Daniel J. “D.J.” Kleinbaum, MCS05: Co-Founder & Co-Chief Executive Officer - Emerald Therapeutics & Emerald Cloud Laboratory
• Jeffrey Leone, MCS82: Chief Executive Officer - Radix Wire & Cable
• Ariel Levavi, MCS07: Software Engineer - Google
• Dr. Robert “Willie” W. Mays, MCS87: Vice President of Regenerative Medicine and Head of Neuroscience - Athersys, Inc.
• Betty C. Mbom, MCS08: Senior Director of Customer Success - Syapse
• Donald “Jeff” Milton, MCS04: Senior Director, Data Sciences - Arcturus Therapeutics, Inc
• Dr. Gurudatta “Guru” Nadkarni, MCS89 MCS93 MCS93: Vice President of Strategic Planning - Consolidated Edison Company
• Dr. Armaghan “Rumi” Naik, MCS02 CS13: Operating Partner - Flagship Pioneering
• Dr. Dietrich A. Stephan, MCS91: Chief Executive Officer - NeuBase Therapeutics
• Karin A. Weisburgh, MCS76: Retired
• Dr. Elizabeth “Betty” S. Woo, MCS82: Vice President/General Manager, Cell & Gene Therapy - Thermo Fisher Scientific